Pembrolizumab plus nab-paclitaxel active as salvage strategy in urothelial carcinoma
Urology Times - Given the efficacy and safety demonstrated, there may be a role going forward for the pembrolizumab/nab-paclitaxel combination in earlier disease
Week-Old COVID-19 Urology Guidelines Already Outdated
posted 6 months
How prostate cancer treatments affect quality of life
posted 7 months
How prostate cancer treatments affect quality of life
posted 7 months
Robotic renal surgery bests open partial nephrectomy
posted 7 months
Robotic renal surgery bests open partial nephrectomy
posted 7 months
Robotic renal surgery bests open partial nephrectomy
posted 7 months
Robotic renal surgery bests open partial nephrectomy
posted 7 months
Robotic renal surgery bests open partial nephrectomy
posted 7 months
Intravesical BCG dosing frequency ‘critical’ in bladder cancer
posted 7 months
EUPROMS: prostate cancer patient-driven QoL
posted 7 months
Kidney Stones: Algorithm Predicts QoL From Patient's Chart
posted 7 months
ProPSMA: PSMA-PET/CT imaging for high risk prostate cancer
posted 7 months
Intravesical BCG dosing frequency ‘critical’ in bladder cancer
posted 7 months
Pembrolizumab plus nab-paclitaxel active as salvage strategy in urothelial carcinoma https://t.co/1ilb75memh #EAU20 #urology #bladdercancer @AndreaNecchi @IstTumori
RT @UrologyTimes: Pembrolizumab plus nab-paclitaxel active as salvage strategy in urothelial carcinoma https://t.co/1ilb75memh #EAU20 #uro…